Page 19 - Tata_Chemicals_yearly-reports-2019-20

Integrated report Statutory reportS Financial StatementS

Agri Sciences Nutritional Sciences Material Sciences Energy Sciences
Priorities going New product Investing in Focussing on HDS for tyre Building < 1 GWh
forward development across microbiome and and other high-growth cell line by 2021 with
segments like crop fermentation- applications and exploring technology from a
protection, nutrition based ingredients, adjacent innovative global leader
and seeds prebiotics, probiotics materials Completing 2-3
and enzymes
International Business Evaluating and executing commercial scale
Development through Shifting from phased capacity expansion energy storage projects
partnerships with traditional to of Silica Scaling Lithium-ion
customers synthetic biotech Scale Nano Zinc Oxide battery recycling
and promote co-
Succeed with development model business into coatings and operations
New formulation with customers additive applications Setting up pilot line to
technology, GMO & Expansion of portfolio into manufacture cathode
Non-GMO traits High quality Natural other nanomaterials aimed active materials
Extracts for food and at healthcare and advanced
pharma industry
applications
KPIs New Product Revenue from FOS Net sales from new Net sales from new
Development-NSDI business business

% revenue from Number of New key customer Start of Production for
new products new projects / accounts won own cell line
Applications added

Number of scientific Adherence to milestones Order pipeline for OEM
publication in key customer business
engagement journey

17